Heart Failure with Preserved Ejection Fraction

Study

Is your heart racing?

About the study sponsored by Diex Recherche:

Heart failure is the shortness of breath that slows you down... day after day.

Shortness of breath during exertion. Daily fatigue. Leg swelling. Difficulty sleeping.

When the heart no longer pumps efficiently, even simple actions can become a challenge.

Despite standard treatments, some continue to see their condition deteriorate. A new clinical study is underway to evaluate a drug in development that could potentially improve heart function and slow the progression of the disease.

Why participate?

Advance science

Your participation could pave the way for more effective treatment for thousands of people living with heart failure.

Benefit from rigorous medical monitoring

Free access to regular assessments, specialized exams, and quality support from our medical team.

Receive financial compensation

Your involvement and time are valuable. Compensation may be offered if you are eligible for the study.

Are you eligible?

We are looking for people who:

- Are 18 years of age or older

- Have been diagnosed with heart failure for at least 3 months

How does it work?

  1. Online Pre-Registration

Complete our confidential form to quickly check if you might be eligible.

  1. Clinical Evaluation

A professional from our team will contact you for a free visit including a medical exam and specific tests.

  1. Study Participation

If you are eligible, you will receive either the study drug or a placebo in a secure, controlled setting. You will be closely monitored by our team throughout the process.

Take a few minutes to complete the form:

I want to apply to this clinical study

Participate in the study of Trois-Rivières Participate in the study of Sherbrooke (West)

For more information, contact us at
819 801-9797 (Trois-Rivières), 819 346-2887 (Sherbrooke (West))
or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.